STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) —  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX).

“We are pleased to announce the closing of this acquisition, as the brands we are adding will strengthen, complement and expand STERIS’s product offerings within our Healthcare segment,” said Dan Carestio, President and Chief Executive Officer of STERIS. “We welcome these teams to STERIS and look forward to working together to enhance our value to our Customers.”

Lazard served as financial advisor to STERIS and Thompson Hine LLP served as legal counsel.

A
bout STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services. For more information, visit www.steris.com.

Company
Contact:

Julie Winter, Vice President, Investor Relations and Corporate Communications
[email protected]

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This release and the referenced conference call may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded “forward-looking statements” under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date the statement is made and may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “targets,” “forecasts,” “outlook,” “impact,” “potential,” “confidence,” “improve,” “optimistic,” “deliver,” “orders,” “backlog,” “comfortable,” “trend”, and “seeks,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in the forward-looking statements including, without limitation, disruption of production or supplies, changes in market conditions, political events, pending or future claims or litigation, competitive factors, technology advances, actions of regulatory agencies, and changes in laws, government regulations, labeling or product approvals or the application or interpretation thereof. Other risk factors are described in STERIS’s other securities filings, including Item 1A of our Annual Report on Form 10-K for the year ended March 31, 2023. Many of these important factors are outside of STERIS’s control. No assurances can be provided as to any result or the timing of any outcome regarding matters described in STERIS’s securities filings or otherwise with respect to any regulatory action, administrative proceedings, government investigations, litigation, warning letters, cost reductions, business strategies, earnings or revenue trends or future financial results. References to products are summaries only and should not be considered the specific terms of the product clearance or literature. Unless legally required, STERIS does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, (a) the impact of the COVID-19 pandemic or similar public health crises on STERIS’s operations, supply chain, material and labor costs, performance, results, prospects, or value, (b) STERIS’s ability to achieve the expected benefits regarding the accounting and tax treatments of the redomiciliation to Ireland (“Redomiciliation”), (c) operating costs, Customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, Customers, clients or suppliers) being greater than expected, (d) STERIS’s ability to successfully integrate the businesses of Cantel Medical into our existing businesses, including unknown or inestimable liabilities, impairments, or increases in expected integration costs or difficulties in connection with the integration of Cantel Medical, (e) uncertainties related to tax treatments under the TCJA and the IRA, (f) the possibility that Pillar Two Model Rules could increase tax uncertainty and adversely impact STERIS’s provision for income taxes and effective tax rate and subject STERIS to additional income tax in jurisdictions who adopt Pillar Two Model Rules, (g) STERIS’s ability to continue to qualify for benefits under certain income tax treaties in light of ratification of more strict income tax treaty rules (through the MLI) in many jurisdictions where STERIS has operations, (h) changes in tax laws or interpretations that could increase our consolidated tax liabilities, including changes in tax laws that would result in STERIS being treated as a domestic corporation for United States federal tax purposes, (i) the potential for increased pressure on pricing or costs that leads to erosion of profit margins, including as a result of inflation, (j) the possibility that market demand will not develop for new technologies, products or applications or services, or business initiatives will take longer, cost more or produce lower benefits than anticipated, (k) the possibility that application of or compliance with laws, court rulings, certifications, regulations, or regulatory actions, including without limitation any of the same relating to FDA, EPA or other regulatory authorities, government investigations, the outcome of any pending or threatened FDA, EPA or other regulatory warning notices, actions, requests, inspections or submissions, the outcome of any pending or threatened litigation brought by private parties, or other requirements or standards may delay, limit or prevent new product or service introductions, affect the production, supply and/or marketing of existing products or services, result in costs to STERIS that may not be covered by insurance, or otherwise affect STERIS’s performance, results, prospects or value, (l) the potential of international unrest, including the Russia-Ukraine military conflict, economic downturn or effects of currencies, tax assessments, tariffs and/or other trade barriers, adjustments or anticipated rates, raw material costs or availability, benefit or retirement plan costs, or other regulatory compliance costs, (m) the possibility of reduced demand, or reductions in the rate of growth in demand, for STERIS’s products and services, (n) the possibility of delays in receipt of orders, order cancellations, or delays in the manufacture or shipment of ordered products, due to supply chain issues or otherwise, or in the provision of services, (o) the possibility that anticipated growth, cost savings, new product acceptance, performance or approvals, or other results may not be achieved, or that transition, labor, competition, timing, execution, impairments, regulatory, governmental, or other issues or risks associated with STERIS’s businesses, industry or initiatives including, without limitation, those matters described in STERIS’s various securities filings, may adversely impact STERIS’s performance, results, prospects or value, (p) the impact on STERIS and its operations, or tax liabilities, of Brexit or the exit of other member countries from the EU, and the Company’s ability to respond to such impacts, (q) the impact on STERIS and its operations of any legislation, regulations or orders, including but not limited to any new trade or tax legislation (including CAMT and excise tax on stock buybacks), regulations or orders, that may be implemented by the U.S. administration or Congress, or of any responses thereto, (r) the possibility that anticipated financial results or benefits of recent acquisitions, including the acquisition of Cantel Medical and Key Surgical, or of STERIS’s restructuring efforts, or of recent divestitures, including anticipated revenue, productivity improvement, cost savings, growth synergies and other anticipated benefits, will not be realized or will be other than anticipated, (s) the increased level of STERIS’s indebtedness incurred in connection with the acquisition of Cantel Medical limiting financial flexibility or increasing future borrowing costs, (t) rating agency actions or other occurrences that could affect STERIS’s existing debt or future ability to borrow funds at rates favorable to STERIS or at all, (u) the effects of changes in credit availability and pricing, as well as the ability of STERIS’s Customers and suppliers to adequately access the credit markets, on favorable terms or at all, when needed, and (v) STERIS’s ability to complete any announced transactions, including the fulfillment of related closing conditions.



Ecolab to Host 2023 Investor Day on September 14

Ecolab to Host 2023 Investor Day on September 14

ST. PAUL, Minn.–(BUSINESS WIRE)–
Ecolab Inc. will host its 2023 Investor Day on Thursday, September 14, starting at 8:00 a.m. (CT) at its Nalco Water headquarters in Naperville, Illinois. The day will include presentations by members of Ecolab’s senior management team and interactive sessions showcasing the company’s latest innovations.

To register to attend the event in person, please contact Ecolab’s investor relations department. As space will be limited, a live webcast of the presentation will be available via the investor section of our website at www.ecolab.com/investor. A replay of the webcast will be available following the event.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on a century of innovation, Ecolab has annual sales of $14 billion, employs more than 47,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, life sciences, hospitality and industrial markets. www.ecolab.com

Follow us on LinkedIn @Ecolab, Twitter @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

(ECL-C)

Andrew Hedberg

+1 651 250 2185

Cairn Clark

+1 651 250 2291

KEYWORDS: Illinois Minnesota United States North America

INDUSTRY KEYWORDS: Restaurant/Bar Other Retail Office Products Sustainability Other Construction & Property Food/Beverage Environment Construction & Property Other Manufacturing Retail Chemicals/Plastics Manufacturing

MEDIA:

Q2 Holdings, Inc. Announces Second Quarter 2023 Financial Results

Q2 Holdings, Inc. Announces Second Quarter 2023 Financial Results

AUSTIN, Texas–(BUSINESS WIRE)–Q2 Holdings, Inc. (NYSE:QTWO), a leading provider of digital transformation solutions for banking and lending, today announced results for its second quarter ending June 30, 2023.

GAAP Results for the Second Quarter 2023

  • Revenue for the second quarter of $154.5 million, up 10 percent year-over-year and up 1 percent from the first quarter of 2023.

  • GAAP gross margin for the second quarter of 47.8 percent, up from 44.8 percent in the prior-year quarter and down from 47.9 percent in the first quarter of 2023.

  • GAAP net loss for the second quarter of $23.6 million compared to GAAP net losses of $25.2 million for the prior-year quarter and $0.5 million for the first quarter of 2023 which included a one-time gain of $19.9 million from partial repurchase of convertible senior notes.

Non-GAAP Results for the Second Quarter 2023

  • Non-GAAP revenue for the second quarter of $154.6 million, up 10 percent year-over-year and up 1 percent from the first quarter of 2023.

  • Non-GAAP gross margin for the second quarter of 54.2 percent, up from 51.3 percent for the prior-year quarter and 54.0 percent for the first quarter of 2023.

  • Adjusted EBITDA for the second quarter of $17.6 million, up from $9.7 million for the prior-year quarter and $16.5 million for the first quarter of 2023.

For a reconciliation of our GAAP to non-GAAP results, please see the tables below.

“We continued our solid bookings performance in the second quarter, closing out our best first half of bookings in company history,” said Q2 CEO Matt Flake. “We also hosted our annual client conference with more than 1,000 customers, partners and prospects in attendance, and the feedback was overwhelmingly positive—they’re excited about our roadmap and continue to believe in the importance of technology in retaining and growing deposits. Lastly, we delivered strong subscription revenue and adjusted EBITDA results for another quarter as we continue to focus on profitable growth.”

Second Quarter Highlights

  • Signed two Tier 1 digital banking contracts including a:

    • Tier 1 bank to utilize a broad set of solutions led by retail banking; and

    • Tier 1 U.S. bank to utilize our retail, small business and commercial banking solutions.
  • Signed two Tier 1 digital lending contracts including a(n):

    • Expansion with a Top 100 U.S. bank utilizing our loan and relationship pricing solutions; and

    • Tier 1 U.S. bank to utilize our loan and relationship pricing solutions.
  • Signed a contract with one of the largest insurance companies in the nation to utilize our Helix platform.

  • Exited the second quarter with approximately 21.7 million registered users on the Q2 digital banking platform, representing 8 percent year-over-year growth and 1 percent sequential growth.

“We were pleased with our results in the quarter, with adjusted EBITDA exceeding the high end of our guidance,” said David Mehok, Q2 CFO. “Our revenue and ARR growth were driven by the ongoing demand for our higher margin subscription businesses. Our continued bookings strength coupled with successful cost initiatives have given us confidence in raising our adjusted EBITDA guidance for the remainder of the year.”

Financial Outlook

As of August 2, 2023, Q2 Holdings is providing guidance for its third quarter of 2023 and updated guidance for its full-year 2023, which represents Q2 Holdings’ current estimates on Q2 Holdings’ operations and financial results. The financial information below represents forward-looking, non-GAAP financial information, including estimates of non-GAAP revenue and adjusted EBITDA. GAAP net loss is the most comparable GAAP measure to adjusted EBITDA. Adjusted EBITDA differs from GAAP net loss in that it excludes items such as depreciation and amortization, stock-based compensation, transaction-related costs, interest and other (income) expense, income taxes, lease and other restructuring charges, (gain) loss on extinguishment of debt and the impact to deferred revenue from purchase accounting. Q2 Holdings is unable to predict with reasonable certainty the ultimate outcome of these exclusions without unreasonable effort. Therefore, Q2 Holdings has not provided guidance for GAAP net loss or a reconciliation of the foregoing forward-looking adjusted EBITDA guidance to GAAP net loss. However, it is important to note that these excluded items could be material to our results computed in accordance with GAAP in future periods.

Q2 Holdings is providing guidance for its third quarter of 2023 as follows:

  • Total non-GAAP revenue of $153.5 million to $156.5 million, which would represent year-over-year growth of 6 percent to 8 percent.

  • Adjusted EBITDA of $17.0 million to $19.0 million, representing 11 to 12 percent of non-GAAP revenue for the quarter.

Q2 Holdings is providing updated guidance for the full-year 2023 as follows:

  • Total non-GAAP revenue of $620.0 million to $628.0 million, which would represent year-over-year growth of 9 percent to 11 percent.

  • Adjusted EBITDA of $71.0 million to $75.0 million, representing 11 to 12 percent of non-GAAP revenue for the year.

Conference Call Details

Date:

Wednesday, August 2, 2023

Time:

5:00 p.m. EDT

Hosts:

Matt Flake, CEO / David Mehok, CFO / Kirk Coleman, President / Jonathan Price, EVP Strategy and Emerging Businesses

Conference Call Registration:

https://conferencingportals.com/event/ZwJrtqJb

Webcast Registration:

https://events.q4inc.com/attendee/728204995

All participants must register using the above links (either the webcast or conference call). A webcast of the conference call and financial results will be accessible from the investor relations section of the Q2 website at http://investors.Q2.com/. In addition, a live conference call dial-in will be available upon registration. Participants should dial in at least 10 minutes before the start of the conference call. An archived replay of the webcast will be available on this website for a limited time after the call. Q2 has used, and intends to continue to use, its investor relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About Q2 Holdings, Inc.

Q2 is a leading provider of digital banking and lending solutions to banks, credit unions, alternative finance companies, and fintechs in the U.S. and internationally. Q2’s comprehensive solution set allows its customers to better onboard, grow and serve their consumer, small business and corporate clients. Headquartered in Austin, Texas, Q2 has offices throughout the world and is publicly traded on the NYSE under the stock symbol QTWO. To learn more, please visit Q2.com. Follow us on LinkedIn and X to stay up-to-date.

Use of Non-GAAP Measures

Q2 uses the following non-GAAP financial measures: non-GAAP revenue; adjusted EBITDA; non-GAAP gross margin; non-GAAP gross profit; non-GAAP sales and marketing expense; non-GAAP research and development expense; non-GAAP general and administrative expense; non-GAAP operating expense; and non-GAAP operating income (loss). Management believes that these non-GAAP financial measures are useful measures of operating performance because they exclude items that Q2 does not consider indicative of its core performance.

In the case of non-GAAP revenue, Q2 adjusts revenue to exclude the impact to deferred revenue from purchase accounting adjustments. In the case of adjusted EBITDA, Q2 adjusts net loss for such items as interest and other (income) expense, taxes, depreciation and amortization, stock-based compensation, transaction-related costs, lease and other restructuring charges, (gain) loss on extinguishment of debt and the impact to deferred revenue from purchase accounting. In the case of non-GAAP gross margin and non-GAAP gross profit, Q2 adjusts gross profit and gross margin for stock-based compensation, amortization of acquired technology, transaction-related costs, lease and other restructuring charges and the impact to deferred revenue from purchase accounting. In the case of non-GAAP sales and marketing expense, non-GAAP research and development expense, and non-GAAP general and administrative expense, Q2 adjusts the corresponding GAAP expense to exclude stock-based compensation. Non-GAAP Operating Expense is calculated by taking the sum of non-GAAP sales and marketing expenses, non-GAAP research and development expense, and non-GAAP general and administrative expense. In the case of non-GAAP operating income (loss), Q2 adjusts operating income (loss), for stock-based compensation, transaction-related costs, amortization of acquired technology, amortization of acquired intangibles, lease and other restructuring charges, and the impact to deferred revenue from purchase accounting.

There are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures are not prepared in accordance with GAAP, do not reflect a comprehensive system of accounting and may not be completely comparable to similarly titled measures of other companies due to potential differences in the exact method of calculation between companies. Certain items that are excluded from these non-GAAP financial measures can have a material impact on operating and net income (loss). As a result, these non-GAAP financial measures have limitations and should be considered in addition to, not as a substitute for or superior to, the closest GAAP measures, or other financial measures prepared in accordance with GAAP. A reconciliation to the closest GAAP measures of these non-GAAP measures is contained in tabular form on the attached unaudited condensed consolidated financial statements.

Q2’s management uses these non-GAAP measures as measures of operating performance; to prepare Q2’s annual operating budget; to allocate resources to enhance the financial performance of Q2’s business; to evaluate the effectiveness of Q2’s business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of Q2’s results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communication with our board of directors concerning Q2’s financial performance.

Forward-looking Statements

This press release contains forward-looking statements, including statements about: customer enthusiasm regarding our roadmap and the importance of technology in retaining and growing deposits; our ability to execute on our focus to grow with improved profitability; our continued bookings strength; the success of our cost initiatives; and, Q2’s quarterly and annual financial guidance. The forward-looking statements contained in this press release are based upon Q2’s historical performance and its current plans, estimates, and expectations and are not a representation that such plans, estimates or expectations will be achieved. Factors that could cause actual results to differ materially from those described herein include risks related to: (a) uncertainties in the financial services industries, including as a result of recent bank failures, and the potential impacts on Q2’s customers’ prospects and Q2’s business sales cycles, Q2’s prospects’ and customers’ spending decisions, including professional services which are more discretionary in nature, and the timing of customer implementation and purchasing decisions; (b) the risk of increased or new competition in Q2’s existing markets and as Q2 enter new markets or new sections of existing markets, or as Q2 offer new solutions; (c) the risks associated with the development of Q2’s solutions and changes to the market for Q2’s solutions compared to Q2’s expectations; (d) quarterly fluctuations in Q2’s operating results relative to Q2’s expectations and guidance and the accuracy of Q2’s forecasts; (e) the risks associated with anticipated higher operating expenses in 2023 and beyond; (f) the impact that rising interest rates, inflation, an economic slowdown, or challenges in the financial services industry, financial markets and credit markets have had to date or in the future could have on account holder or end user, or End User, usage of Q2’s solutions, including the promotion and adoption of Q2’s Helix and payment solutions, and on Q2’s customers’ prospects and Q2’s business sales cycles, Q2’s prospects’ and customers’ spending decisions, including professional services which are more discretionary in nature, and the timing of customer implementation and purchasing decisions; (g) the risks and increased costs associated with managing growth and the challenges associated with improving operations and hiring, retaining and motivating employees to support such growth, particularly in light of the macroeconomic impacts of the novel coronavirus disease, or COVID-19, including increased employee turnover, labor shortages, wage inflation and extreme competition for talent; (h) the risk that the residual impacts of the COVID-19 pandemic continue to or that any renewed efforts to limit its spread could negatively impact or disrupt the markets for Q2’s solutions and that the markets for Q2’s solutions do not return to normal or grow as anticipated; (i) the risks associated with Q2’s transactional business which are typically driven by end-user behavior which can be influenced by external drivers outside of Q2’s control; (j) the risks associated with effectively managing Q2’s cost structure in light of the challenging macroeconomic environment, challenges in the financial services industry and from the effects of seasonal or other unexpected trends; (k) the risks associated with the general economic and geopolitical uncertainties, including the heightened risk of state-sponsored cyberattacks on financial services and other critical infrastructure, and continued or increased inflation partially driven by increased energy costs or other unpredictable economic impacts that have and may continue to negatively affect demand for Q2’s solutions; (l) the risks associated with managing Q2’s business in response to continued challenging macroeconomic conditions, challenges in the financial services industry and any anticipated or resulting recession; (m) the risks associated with accurately forecasting and managing the impacts of any macroeconomic downturn or challenges in the financial services industry on Q2’s customers and their end users, including in particular the impacts of any downturn on financial technology companies, or FinTechs, or alternative finance companies, or Alt-FIs, and Q2’s arrangements with them, which represent a newer market opportunity for us, a more complex revenue model for us and which may be more vulnerable to an economic downturn than Q2’s financial institution customers; (n) the challenges and costs associated with selling, implementing and supporting Q2’s solutions, particularly for larger customers with more complex requirements and longer implementation processes, including risks related to the timing and predictability of sales of Q2’s solutions and the impact that the timing of bookings may have on Q2’s revenue and financial performance in a period; (o) the risk that errors, interruptions or delays in Q2’s solutions or Web hosting negatively impacts Q2’s business and sales; (p) the risks associated with cyberattacks, data and privacy breaches and breaches of security measures within Q2’s products, systems and infrastructure or the products, systems and infrastructure of third parties upon which Q2 relies and the resultant costs and liabilities and harm to Q2’s business and reputation and Q2’s ability to sell Q2’s solutions; (q) the difficulties and risks associated with developing and selling complex new solutions and enhancements with the technical and regulatory specifications and functionality required by Q2’s customers and relevant governmental authorities; (r) regulatory risks, including risks related to evolving regulation of artificial intelligence, or AI, machine learning and the receipt, collection, storage, processing and transfer of data; (s) the risks associated with Q2’s sales and marketing capabilities, including partner relationships and the length, cost and unpredictability of Q2’s sales cycle; (t) the risks inherent in third-party technology and implementation partnerships that could cause harm to Q2’s business; (u) the risk that Q2 will not be able to maintain historical contract terms such as pricing and duration; (v) the general risks associated with the complexity of Q2’s customer arrangements and Q2’s solutions; (w) the risks associated with integrating acquired companies and successfully selling and maintaining their solutions; (x) litigation related to intellectual property and other matters and any related claims, negotiations and settlements; (y) the risks associated with further consolidation in the financial services industry; (z) the risks associated with selling Q2’s solutions internationally and with the recent expansion of Q2’s international operations; and (aa) the risk that Q2’s debt repayment obligations may adversely affect Q2’s financial condition and cash flows from operations in the future and that Q2 may not be able to obtain capital when desired or needed on favorable terms.

Additional information relating to the uncertainty affecting the Q2 business is contained in Q2’s filings with the Securities and Exchange Commission. These documents are available on the SEC Filings section of the Investor Relations section of Q2’s website at http://investors.Q2.com/. These forward-looking statements represent Q2’s expectations as of the date of this press release. Subsequent events may cause these expectations to change, and Q2 disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise.

Q2 Holdings, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

 

June 30, 2023

 

December 31, 2022

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

118,229

 

 

$

199,600

 

Restricted cash

 

 

2,298

 

 

 

2,302

 

Investments

 

 

161,777

 

 

 

233,753

 

Accounts receivable, net

 

 

38,671

 

 

 

46,735

 

Contract assets, current portion, net

 

 

11,359

 

 

 

8,909

 

Prepaid expenses and other current assets

 

 

11,949

 

 

 

10,832

 

Deferred solution and other costs, current portion

 

 

26,783

 

 

 

21,117

 

Deferred implementation costs, current portion

 

 

8,136

 

 

 

7,828

 

Total current assets

 

 

379,202

 

 

 

531,076

 

Property and equipment, net

 

 

48,460

 

 

 

56,695

 

Right of use assets

 

 

35,579

 

 

 

39,837

 

Deferred solution and other costs, net of current portion

 

 

27,303

 

 

 

26,410

 

Deferred implementation costs, net of current portion

 

 

21,025

 

 

 

18,713

 

Intangible assets, net

 

 

134,691

 

 

 

145,681

 

Goodwill

 

 

512,869

 

 

 

512,869

 

Contract assets, net of current portion and allowance

 

 

11,571

 

 

 

16,186

 

Other long-term assets

 

 

1,987

 

 

 

2,259

 

Total assets

 

$

1,172,687

 

 

$

1,349,726

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable and accrued liabilities

 

$

48,223

 

 

$

54,263

 

Convertible notes, current portion

 

 

 

 

 

10,903

 

Deferred revenues, current portion

 

 

111,466

 

 

 

117,468

 

Lease liabilities, current portion

 

 

9,210

 

 

 

9,408

 

Total current liabilities

 

 

168,899

 

 

 

192,042

 

Convertible notes, net of current portion

 

 

489,473

 

 

 

657,789

 

Deferred revenues, net of current portion

 

 

19,682

 

 

 

21,691

 

Lease liabilities, net of current portion

 

 

48,696

 

 

 

52,991

 

Other long-term liabilities

 

 

4,530

 

 

 

6,189

 

Total liabilities

 

 

731,280

 

 

 

930,702

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

Common stock

 

 

6

 

 

 

6

 

Additional paid-in capital

 

 

1,027,796

 

 

 

982,300

 

Accumulated other comprehensive loss

 

 

(1,947

)

 

 

(2,972

)

Accumulated deficit

 

 

(584,448

)

 

 

(560,310

)

Total stockholders’ equity

 

 

441,407

 

 

 

419,024

 

Total liabilities and stockholders’ equity

 

$

1,172,687

 

 

$

1,349,726

 

Q2 Holdings, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

Revenues (1)

 

$

154,531

 

 

$

140,309

 

 

$

307,539

 

 

$

274,380

 

Cost of revenues (2)

 

 

80,703

 

 

 

77,421

 

 

 

160,414

 

 

 

151,093

 

Gross profit

 

 

73,828

 

 

 

62,888

 

 

 

147,125

 

 

 

123,287

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Sales and marketing

 

 

28,701

 

 

 

26,477

 

 

 

56,845

 

 

 

51,743

 

Research and development

 

 

34,096

 

 

 

31,832

 

 

 

68,521

 

 

 

62,963

 

General and administrative

 

 

27,127

 

 

 

23,285

 

 

 

51,819

 

 

 

43,853

 

Transaction-related costs

 

 

9

 

 

 

527

 

 

 

21

 

 

 

530

 

Amortization of acquired intangibles

 

 

5,252

 

 

 

4,422

 

 

 

10,514

 

 

 

8,844

 

Lease and other restructuring charges

 

 

2,312

 

 

 

129

 

 

 

4,273

 

 

 

537

 

Total operating expenses

 

 

97,497

 

 

 

86,672

 

 

 

191,993

 

 

 

168,470

 

Loss from operations

 

 

(23,669

)

 

 

(23,784

)

 

 

(44,868

)

 

 

(45,183

)

Total other income (expense), net (3)

 

 

526

 

 

 

(1,098

)

 

 

21,227

 

 

 

(1,894

)

Loss before income taxes

 

 

(23,143

)

 

 

(24,882

)

 

 

(23,641

)

 

 

(47,077

)

Provision for income taxes

 

 

(479

)

 

 

(340

)

 

 

(497

)

 

 

(1,704

)

Net loss

 

$

(23,622

)

 

$

(25,222

)

 

$

(24,138

)

 

$

(48,781

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale investments

 

 

(174

)

 

 

(544

)

 

 

862

 

 

 

(1,617

)

Foreign currency translation adjustment

 

 

180

 

 

 

(724

)

 

 

163

 

 

 

(814

)

Comprehensive loss

 

$

(23,616

)

 

$

(26,490

)

 

$

(23,113

)

 

$

(51,212

)

 

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

 

Net loss per common share, basic and diluted

 

$

(0.41

)

 

$

(0.44

)

 

$

(0.42

)

 

$

(0.85

)

Weighted average common shares outstanding, basic and diluted

 

 

58,286

 

 

 

57,234

 

 

 

58,087

 

 

 

57,125

 

(1)

Includes deferred revenue reduction from purchase accounting of $0.1 million and $0.2 million for the three months ended June 30, 2023 and 2022, respectively, and $0.2 million and $0.4 million for the six months ended June 30, 2023 and 2022, respectively.

 

(2)

Includes amortization of acquired technology of $5.9 million and $5.6 million for the three months ended June 30, 2023 and 2022, respectively, and $11.8 million and $11.2 million for the six months ended June 30, 2023 and 2022, respectively.

 

(3)

Includes a gain of $19.9 million related to the early extinguishment of a portion of our 2026 Notes and 2025 Notes for the six months ended June 30, 2023.

Q2 Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

 

Six Months Ended June 30,

 

 

2023

 

2022

Cash flows from operating activities:

 

 

 

 

Net loss

 

$

(24,138

)

 

$

(48,781

)

Adjustments to reconcile net loss to net cash from operating activities:

 

 

 

 

Amortization of deferred implementation, solution and other costs

 

 

12,447

 

 

 

11,091

 

Depreciation and amortization

 

 

35,478

 

 

 

29,946

 

Amortization of debt issuance costs

 

 

1,113

 

 

 

1,367

 

Amortization of premiums on investments

 

 

(1,781

)

 

 

577

 

Stock-based compensation expense

 

 

38,710

 

 

 

33,425

 

Deferred income taxes

 

 

(556

)

 

 

857

 

(Gain) loss on extinguishment of debt

 

 

(19,312

)

 

 

 

Other non-cash charges

 

 

2,043

 

 

 

883

 

Changes in operating assets and liabilities

 

 

(27,042

)

 

 

(43,185

)

Net cash provided by (used in) operating activities

 

 

16,962

 

 

 

(13,820

)

Cash flows from investing activities:

 

 

 

 

Net maturities (purchases) of investments

 

 

74,284

 

 

 

(85,555

)

Purchases of property and equipment

 

 

(3,294

)

 

 

(5,097

)

Capitalized software development costs

 

 

(13,127

)

 

 

(9,485

)

Net cash provided by (used in) investing activities

 

 

57,863

 

 

 

(100,137

)

Cash flows from financing activities:

 

 

 

 

Payment for maturity of 2023 convertible notes

 

 

(10,908

)

 

 

 

Payments for repurchases of convertible notes

 

 

(149,640

)

 

 

 

Proceeds from capped calls related to convertible notes

 

 

139

 

 

 

 

Proceeds from exercise of stock options and ESPP

 

 

3,933

 

 

 

2,803

 

Net cash provided by (used in) financing activities

 

 

(156,476

)

 

 

2,803

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

276

 

 

 

(575

)

Net decrease in cash, cash equivalents, and restricted cash

 

 

(81,375

)

 

 

(111,729

)

Cash, cash equivalents, and restricted cash, beginning of period

 

 

201,902

 

 

 

325,821

 

Cash, cash equivalents, and restricted cash, end of period

 

$

120,527

 

 

$

214,092

 

Q2 Holdings, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(in thousands)

(unaudited)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2023

 

2022

 

2023

 

2022

GAAP revenue

 

$

154,531

 

 

$

140,309

 

 

$

307,539

 

 

$

274,380

 

Deferred revenue reduction from purchase accounting

 

 

83

 

 

 

169

 

 

 

199

 

 

 

411

 

Non-GAAP revenue

 

$

154,614

 

 

$

140,478

 

 

$

307,738

 

 

$

274,791

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

 

$

73,828

 

 

$

62,888

 

 

$

147,125

 

 

$

123,287

 

Stock-based compensation

 

 

3,577

 

 

 

3,335

 

 

 

6,950

 

 

 

6,074

 

Amortization of acquired technology

 

 

5,883

 

 

 

5,603

 

 

 

11,763

 

 

 

11,207

 

Transaction-related costs

 

 

 

 

 

 

 

 

 

 

 

 

Lease and other restructuring charges

 

 

429

 

 

 

 

 

 

429

 

 

 

 

Deferred revenue reduction from purchase accounting

 

 

83

 

 

 

169

 

 

 

199

 

 

 

411

 

Non-GAAP gross profit

 

$

83,800

 

 

$

71,995

 

 

$

166,466

 

 

$

140,979

 

 

 

 

 

 

 

 

 

 

Non-GAAP gross margin:

 

 

 

 

 

 

 

 

Non-GAAP gross profit

 

$

83,800

 

 

$

71,995

 

 

$

166,466

 

 

$

140,979

 

Non-GAAP revenue

 

 

154,614

 

 

 

140,478

 

 

 

307,738

 

 

 

274,791

 

Non-GAAP gross margin

 

 

54.2

%

 

 

51.3

%

 

 

54.1

%

 

 

51.3

%

 

 

 

 

 

 

 

 

 

GAAP sales and marketing expense

 

$

28,701

 

 

$

26,477

 

 

$

56,845

 

 

$

51,743

 

Stock-based compensation

 

 

(4,823

)

 

 

(4,012

)

 

 

(9,083

)

 

 

(7,338

)

Non-GAAP sales and marketing expense

 

$

23,878

 

 

$

22,465

 

 

$

47,762

 

 

$

44,405

 

 

 

 

 

 

 

 

 

 

GAAP research and development expense

 

$

34,096

 

 

$

31,832

 

 

$

68,521

 

 

$

62,963

 

Stock-based compensation

 

 

(4,007

)

 

 

(3,850

)

 

 

(7,783

)

 

 

(6,702

)

Non-GAAP research and development expense

 

$

30,089

 

 

$

27,982

 

 

$

60,738

 

 

$

56,261

 

 

 

 

 

 

 

 

 

 

GAAP general and administrative expense

 

$

27,127

 

 

$

23,285

 

 

$

51,819

 

 

$

43,853

 

Stock-based compensation

 

 

(8,217

)

 

 

(6,320

)

 

 

(14,894

)

 

 

(11,422

)

Non-GAAP general and administrative expense

 

$

18,910

 

 

$

16,965

 

 

$

36,925

 

 

$

32,431

 

 

 

 

 

 

 

 

 

 

GAAP operating loss

 

$

(23,669

)

 

$

(23,784

)

 

$

(44,868

)

 

$

(45,183

)

Deferred revenue reduction from purchase accounting

 

 

83

 

 

 

169

 

 

 

199

 

 

 

411

 

Stock-based compensation

 

 

20,624

 

 

 

17,517

 

 

 

38,710

 

 

 

31,536

 

Transaction-related costs

 

 

9

 

 

 

527

 

 

 

21

 

 

 

530

 

Amortization of acquired technology

 

 

5,883

 

 

 

5,603

 

 

 

11,763

 

 

 

11,207

 

Amortization of acquired intangibles

 

 

5,252

 

 

 

4,422

 

 

 

10,514

 

 

 

8,844

 

Lease and other restructuring charges

 

 

2,741

 

 

 

129

 

 

 

4,702

 

 

 

537

 

Non-GAAP operating income

 

$

10,923

 

 

$

4,583

 

 

$

21,041

 

 

$

7,882

 

 

 

 

 

 

 

 

 

 

Reconciliation of GAAP net loss to adjusted EBITDA:

 

 

 

 

 

 

 

 

GAAP net loss

 

$

(23,622

)

 

$

(25,222

)

 

$

(24,138

)

 

$

(48,781

)

Depreciation and amortization

 

 

17,935

 

 

 

15,027

 

 

 

35,478

 

 

 

29,946

 

Stock-based compensation

 

 

20,624

 

 

 

17,517

 

 

 

38,710

 

 

 

31,536

 

Provision for income taxes

 

 

479

 

 

 

340

 

 

 

497

 

 

 

1,704

 

Interest and other (income) expense, net

 

 

(623

)

 

 

1,176

 

 

 

(1,502

)

 

 

1,838

 

Transaction-related costs

 

 

9

 

 

 

527

 

 

 

21

 

 

 

530

 

Lease and other restructuring charges

 

 

2,741

 

 

 

129

 

 

 

4,702

 

 

 

537

 

(Gain) loss on extinguishment of debt

 

 

 

 

 

 

 

 

(19,869

)

 

 

 

Deferred revenue reduction from purchase accounting

 

 

83

 

 

 

169

 

 

 

199

 

 

 

411

 

Adjusted EBITDA

 

$

17,626

 

 

$

9,663

 

 

$

34,098

 

 

$

17,721

 

Q2 Holdings, Inc.

Reconciliation of GAAP to Non-GAAP Revenue Outlook

(in thousands)

 

 

 

Q3 2023 Outlook

 

Full Year 2023 Outlook

 

 

Low

 

High

 

Low

 

High

 

 

 

 

 

 

 

 

 

GAAP revenue

 

$

153,424

 

$

156,424

 

$

619,655

 

$

627,655

Deferred revenue reduction from purchase accounting

 

 

76

 

 

76

 

 

345

 

 

345

Non-GAAP revenue

 

$

153,500

 

$

156,500

 

$

620,000

 

$

628,000

 

MEDIA CONTACT:

Jean Kondo

Q2 Holdings, Inc.

M: +1-510-823-4728

[email protected]

INVESTOR CONTACT:

Josh Yankovich

Q2 Holdings, Inc.

O: +1-512-682-4463

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Data Management Banking Technology Professional Services Payments Security Software Internet Fintech Mobile/Wireless Finance

MEDIA:

Logo
Logo

Advance Auto Parts Announces Dates for Its Second Quarter 2023 Earnings Release and Conference Call

Advance Auto Parts Announces Dates for Its Second Quarter 2023 Earnings Release and Conference Call

RALEIGH, N.C.–(BUSINESS WIRE)–
Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America that serves both professional installer and do-it-yourself customers, will report its second quarter 2023 results before the market opens on Wednesday, August 23, 2023. Interested parties can listen to the event via a webcast scheduled to begin at 8:00 a.m. Eastern Time on Wednesday, August 23, 2023. The webcast will be accessible via the company’s Investor Relations website (ir.AdvanceAutoParts.com).

To join by phone, please pre-register online for dial-in and passcode information. Upon registering, participants will receive a confirmation with call details and a registrant ID. While registration is open through the live call, the company suggests registering a day in advance or at minimum 10 minutes before the start of the call. A replay of the conference call will be available on the company’s Investor Relations website for one year.

About Advance Auto Parts

Advance Auto Parts, Inc. is a leading automotive aftermarket parts provider that serves both professional installer and do-it-yourself customers. As of April 22, 2023, Advance operated 4,778 stores and 318 Worldpac branches primarily within the United States, with additional locations in Canada, Puerto Rico and the U.S. Virgin Islands. The company also served 1,315 independently owned Carquest branded stores across these locations in addition to Mexico and various Caribbean islands. Additional information about Advance, including employment opportunities, customer services, and online shopping for parts, accessories and other offerings can be found at www.AdvanceAutoParts.com.

Investor Relations:

Elisabeth Eisleben

T: (919) 227-5466

E: [email protected]

Media:

Darryl Carr

T: (984) 389-7207

E: [email protected]

KEYWORDS: West Virginia Virginia North Carolina New York Florida District of Columbia United States North America

INDUSTRY KEYWORDS: Aftermarket Automotive General Automotive Other Retail Automotive Manufacturing Specialty Manufacturing Other Automotive Retail

MEDIA:

Logo
Logo

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow

TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its second quarter 2023 financial results after market close on Wednesday, August 9, 2023.

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.

Second Quarter 2023 Results Conference Call Details:

Date: Wednesday, August 9, 2023
Time: 4:30 p.m. ET
Live Call Registration: https://register.vevent.com/register/BI89a039deab82494a8b81525d3b60d614
   

The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.

About Profound Medical Corp.

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.

Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO® is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum to help preserve the patient’s natural functional abilities. TULSA-PRO® has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer, and the transition zone in large volume benign prostatic hyperplasia (“BPH”). TULSA-PRO® is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (“FDA”).

Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve® where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.

For further information, please contact:

Stephen Kilmer
Investor Relations
[email protected]
T: 647.872.4849



Butterfield Cautions Shareholders Regarding New York Stock and Bond LLC Mini-tender Offer for Shares

Butterfield Cautions Shareholders Regarding New York Stock and Bond LLC Mini-tender Offer for Shares

HAMILTON, Bermuda–(BUSINESS WIRE)–
The Bank of N.T. Butterfield & Son Limited (“Butterfield”) (NYSE: NTB | BSX: NTB.BH) has been notified of an unsolicited offer made by New York Stock and Bond LLC to purchase up to 50,000 of Butterfield’s ordinary shares, or approximately 0.1% of shares outstanding, at a price of £15 per share.

Butterfield cautions shareholders that the mini-tender offer has been made at a price below the current market price for Butterfield shares. The offer represents a discount of approximately 38% below the closing price on the NYSE on July 21, 2023 (the date referenced in the offer circular). Butterfield does not recommend or endorse acceptance of this unsolicited mini-tender offer and is not associated in any way with New York Stock and Bond LLC, its mini-tender offer or the offer documentation.

Mini-tender offers are designed to seek not more than 5% of a company’s outstanding shares, thereby avoiding disclosure and procedural requirements applicable to most bids under U.S. securities regulations. The U.S. Securities and Exchange Commission (the “SEC”) has expressed concerns about mini-tender offers, including the possibility that investors might tender to such offers without understanding the offer price relative to the actual market price of their securities.

The SEC has cautioned investors about these offers, noting that “some bidders make mini-tender offers at below-market prices, hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price.” The SEC’s guidance to investors on mini-tenders is available at https://www.sec.gov/rules/interp/34-43069.htm.

Shareholders should carefully review the offer documentation, obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to New York Stock and Bond LLC’s mini-tender offer. Butterfield requests that a copy of this news release be included with all distributions of materials related to New York Stock and Bond LLC’s mini-tender offer for Butterfield’s ordinary shares.

About Butterfield:

Butterfield is a full-service bank and wealth manager headquartered in Hamilton, Bermuda, providing services to clients from Bermuda, the Cayman Islands, Guernsey and Jersey, where our principal banking operations are located, and The Bahamas, Switzerland, Singapore and the United Kingdom, where we offer specialized financial services. Banking services comprise deposit, cash management and lending solutions for individual, business and institutional clients. Wealth management services are composed of trust, private banking, asset management and custody. In Bermuda, the Cayman Islands and Guernsey, we offer both banking and wealth management. In The Bahamas, Singapore and Switzerland, we offer select wealth management services. In the UK, we offer residential property lending. In Jersey, we offer select banking and wealth management services. Butterfield is publicly traded on the New York Stock Exchange (symbol: NTB) and the Bermuda Stock Exchange (symbol: NTB.BH). Further details on the Butterfield Group can be obtained from our website at: www.butterfieldgroup.com.

BF-All

Investor Relations Contact:

Noah Fields

Investor Relations

The Bank of N.T. Butterfield & Son Limited

Phone : (441) 299 3816

E-mail : [email protected]

Media Relations Contact:

Nicky Stevens

Group Strategic Marketing & Communications

The Bank of N.T. Butterfield & Son Limited

Phone: (441) 299 1624

Cellular: (441) 524 4106

E-mail: [email protected]

KEYWORDS: Caribbean United States Bahamas North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

BWXT Awarded an Engineering Contract from TerraPower for the Natrium™ Demonstration Project

BWXT Awarded an Engineering Contract from TerraPower for the Natrium™ Demonstration Project

CAMBRIDGE, Ontario–(BUSINESS WIRE)–
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with TerraPower to design the Intermediate Heat Exchanger for the Natrium Demonstration Project.

The Natrium technology is a 345-megawatt sodium fast reactor coupled with a molten salt-based integrated energy storage system. The Intermediate Heat Exchanger is a critical component of the Natrium advanced reactor. It transfers heat from the primary sodium in the primary heat transport system to the intermediate heat transport system. This work will start from conceptual design, preliminary design and final detailed design activities of the Intermediate Heat Exchanger, and be performed by BWXT Canada Ltd. in Cambridge, Ontario.

“BWXT has the required experience and expertise in commercial nuclear innovation to serve the fast-growing global advanced reactor market,” said John MacQuarrie, president of BWXT Commercial Operations. “We are pleased to work with TerraPower to execute this contract and look forward to meeting our commitments while expanding our role in accelerating the supply of clean energy in North America.”

In November 2021, TerraPower announced Kemmerer, Wyoming as the preferred site for the Natrium Demonstration Project, one of two competitively-selected advanced reactor demonstration projects (ARDP) supported by the U.S. Department of Energy (DOE). Successful design of the Intermediate Heat Exchanger by BWXT Canada Ltd. is key to the planned achievements of the Natrium Demonstration Project’s power generation.

BWXT is a global leader in the design, manufacture and service of commercial nuclear components. As a result of its investments in people and facilities, BWXT has become an essential partner in the delivery of nuclear projects, supporting customers’ commitment to generating clean, reliable, low-cost electricity for communities and businesses.

Forward Looking Statements

BWXT cautions that this release contains forward-looking statements, including statements relating to the performance, design, suitability and impact of the Intermediate Heat Exchanger to be designed by BWXT under the contract with TerraPower. These forward-looking statements involve a number of risks and uncertainties, including, among other things, modification or termination of the project, execution of future contracts and delays. If one or more of these or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, please see BWXT’s annual report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.

About BWXT

At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. Headquartered in Lynchburg, Virginia, BWXT is a Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine and space exploration. With approximately 7,000 employees, BWXT has 14 major operating sites in the U.S., Canada and the U.K. In addition, BWXT joint ventures provide management and operations at a dozen U.S. Department of Energy and NASA facilities. BWXT’s Commercial Operations has over 60 years of expertise and experience in the design, manufacturing, commissioning and service of nuclear power generation equipment. This includes steam generators, nuclear fuel and fuel components, critical plant components, parts and related plant services. Follow us on Twitter at @BWXT and learn more at www.bwxt.com.

Media Contact

Monifa Miller

Senior Director, Corporate Affairs

Commercial Operations

519.242.8071 [email protected]

Investor Contact

Chase Jacobson

Vice President, Investor Relations

980.365.4300 [email protected]

KEYWORDS: Virginia United States North America Canada

INDUSTRY KEYWORDS: Other Defense Contracts Utilities Nuclear Energy Technology Defense Government Technology Engineering Aerospace Other Technology Manufacturing

MEDIA:

Logo
Logo

Superior Drilling Products, Inc. Enters Into New Loan and Line of Credit Agreement

Superior Drilling Products, Inc. Enters Into New Loan and Line of Credit Agreement

New facilities extend maturity dates and include more favorable financing terms

VERNAL, Utah–(BUSINESS WIRE)–Superior Drilling Products, Inc. (NYSE American: SDPI) (“SDP” or the “Company”), a designer and manufacturer of drilling tool technologies, announced that on July 28, 2023, it executed a new credit agreement with Vast Bank, National Association, which included a 5-year, $1.7 million term loan, a 2-year, $750,000 revolving credit line, and a program whereby the lender can purchase certain accounts receivable. The proceeds from the receivables program were used to repay the full amount outstanding under the Company’s existing credit agreement. The funds available through the term loan and the revolving line can be used for working capital and growth capital purposes.

“This new credit agreement extends our maturity dates and includes more favorable financing terms than our previous debt arrangements, which we believe is a reflection of our growing financial strength,” commented Chis Cashion, Chief Financial Officer. “While we expect to continue to generate strong operating cash flow to support our growth strategy, the new credit agreement also provides additional financial flexibility and liquidity.”

The amount available under the revolving line will be the lesser of $750,000 or the borrowing base, which is as of a date 50% of eligible inventory as calculated under the loan agreement. The interest rate on the revolving line will be the greater of prime plus 1.00% or 7.50%. The interest rate on the term loan is fixed at 8.18%.

In addition, in connection with entering into the new loan agreement, the Company entered into business manager agreements for the purchase by the lender of certain domestic and international accounts receivable of the Company. The face amount of the accounts that may be purchased cannot exceed $2.5 million under the domestic agreement and $2.0 million under the international agreement.

About Superior Drilling Products, Inc.

Superior Drilling Products, Inc. is an innovative, cutting-edge drilling tool technology company providing cost saving solutions that drive production efficiencies for the oil and natural gas drilling industry. The Company designs, manufactures, repairs and sells drilling tools. SDP drilling solutions include the patented Drill-N-Ream® well bore conditioning tool and the patented Strider™ oscillation system technology. In addition, SDP is a manufacturer and refurbisher of PDC (polycrystalline diamond compact) drill bits for a leading oil field service company. SDP operates a state-of-the-art drill tool fabrication facility, where it manufactures its solutions for the drilling industry, as well as customers’ custom products. The Company’s strategy for growth is to leverage its expertise in drill tool technology and innovative, precision machining in order to broaden its product offerings and solutions for the oil and gas industry.

Additional information about the Company can be found at: sdpi.com.

Safe Harbor Regarding Forward Looking Statements

This news release contains forward-looking statements and information that are subject to a number of risks and uncertainties, many of which are beyond our control. All statements, other than statements of historical fact included in this release, including, without limitations, the Company’s strategic review process, the continued impact of COVID-19 on the business, the Company’s strategy, future operations, success at developing future tools, the Company’s effectiveness at executing its business strategy and plans, financial position, estimated revenue and losses, projected costs, prospects, plans and objectives of management, and ability to outperform are forward-looking statements. The use of words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project”, “forecast,” “should” or “plan, and similar expressions are intended to identify forward-looking statements, although not all forward -looking statements contain such identifying words. These statements reflect the beliefs and expectations of the Company and are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, the duration of the COVID-19 pandemic and related impact on the oil and natural gas industry, the effectiveness of success at expansion in the Middle East, options available for market channels in North America, the deferral of the commercialization of the Strider technology, the success of the Company’s business strategy and prospects for growth; the market success of the Company’s specialized tools, effectiveness of its sales efforts, its cash flow and liquidity; financial projections and actual operating results; the amount, nature and timing of capital expenditures; the availability and terms of capital; competition and government regulations; and general economic conditions. These and other factors could adversely affect the outcome and financial effects of the Company’s plans and described herein. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, contact investor relations:

Deborah K. Pawlowski / Craig P. Mychajluk

Kei Advisors LLC

716-843-3908 / 716-843-3832

[email protected] / [email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Mining/Minerals Oil/Gas Manufacturing Energy Natural Resources Other Manufacturing

MEDIA:

Logo
Logo

Star Group, L.P. Reports Fiscal 2023 Third Quarter Results

STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE:SGU), a home energy distributor and services provider, today announced financial results for its fiscal 2023 third quarter ended June 30, 2023.

Three Months Ended June 30, 2023 Compared to the Three Months Ended June 30, 2022

For the fiscal 2023 third quarter, Star reported a 31.7 percent decline in revenue, to $300.1 million, compared with $439.1 million in the prior-year period, reflecting a decrease in total volume sold and a decrease in average selling prices.

The volume of home heating oil and propane sold during the fiscal 2023 third quarter decreased by 10.6 million gallons, or 26.2 percent, to 30.1 million gallons due to the impact of warmer weather, net customer attrition and other factors. Temperatures in Star’s geographic areas of operation for the fiscal 2023 third quarter were 12.3 percent warmer than during the fiscal 2022 third quarter and 19.4 percent warmer than normal, as reported by the National Oceanic and Atmospheric Administration.

Star’s net loss increased by $13.3 million in the quarter, to $23.9 million, primarily due an increase in Adjusted EBITDA loss of $11.8 million, an unfavorable change in the fair value of derivative instruments of $6.6 million and a $0.8 million increase in interest expense, partially offset by a $5.5 million increase in income tax benefit.

Third quarter Adjusted EBITDA loss increased by $11.8 million, to $22.9 million, compared to the three months ended June 30, 2022, as the decline in home heating oil and propane volume more than offset an increase in per gallon margins.

“While the weather this quarter was much warmer than anticipated, we have maintained our focus on customer retention and providing excellent service,” said Jeff Woosnam, Star Group’s President and Chief Executive Officer. “Year-to-date, temperatures were the third warmest on record over the past 123 years in the New York City metropolitan area, impacting overall results. However, we are in a very strong position from a liquidity standpoint given that product costs are down approximately $0.60 per gallon year-over-year. In addition, we have approximately $57 million in cash on the balance sheet, as well as approximately $218 million of availability under our bank agreement to fund growth, and a modest leverage ratio in a year that’s been extremely mild. We are making the most of the non-heating season – investigating possible acquisitions, working on home HVAC repairs and upgrades, controlling operating expenses, and preparing for colder days ahead. As we near the end of fiscal 2023, we believe the Company is well positioned for whatever weather comes our way.”

Nine Months Ended June 30, 2023 Compared to the Nine Months Ended June 30, 2022

For the nine months ended June 30, 2023, Star reported nearly flat revenue year-over-year of $1.7 billion, reflecting a decrease in total volume sold, nearly offset by an increase in selling prices in response to higher wholesale product costs.

The volume of home heating oil and propane sold during the first nine months of fiscal 2023 decreased by 36.3 million gallons, or 13.1 percent, to 240.4 million gallons as the additional volume provided from acquisitions was more than offset by warmer temperatures, net customer attrition and other factors. Temperatures in Star’s geographic areas of operation fiscal year-to-date were 7.7 percent warmer than during the prior-year period and 16.3 percent warmer than normal, as reported by the National Oceanic and Atmospheric Administration.

Star’s net income declined by $33.6 million for the first nine months of fiscal 2023, to $51.7 million, primarily due to an unfavorable change in the fair value of derivative instruments of $31.5 million, lower Adjusted EBITDA of $12.8 million and a $5.2 million increase in interest expense, partially offset by a $14.6 million decrease in income tax expense. 

Year-to-date Adjusted EBITDA decreased by $12.8 million, to $128.3 million, compared to the prior-year period as a decline in home heating oil and propane volume more than offset an increase in per gallon margins and an $11.4 million higher benefit recorded under the Company’s weather hedge.

EBITDA and Adjusted EBITDA (Non-GAAP Financial Measures)

EBITDA (Earnings from continuing operations before net interest expense, income taxes, depreciation and amortization) and Adjusted EBITDA (Earnings from continuing operations before net interest expense, income taxes, depreciation and amortization, (increase) decrease in the fair value of derivatives, other income (loss), net, multiemployer pension plan withdrawal charge, gain or loss on debt redemption, goodwill impairment, and other non-cash and non-operating charges) are non-GAAP financial measures that are used as supplemental financial measures by management and external users of the Company’s financial statements, such as investors, commercial banks and research analysts, to assess Star’s position with regard to the following:

  • compliance with certain financial covenants included in our debt agreements;
  • financial performance without regard to financing methods, capital structure, income taxes or historical cost basis;
  • operating performance and return on invested capital compared to those of other companies in the retail distribution of refined petroleum products, without regard to financing methods and capital structure;
  • ability to generate cash sufficient to pay interest on our indebtedness and to make distributions to our partners; and
  • the viability of acquisitions and capital expenditure projects and the overall rates of return of alternative investment opportunities.

The method of calculating Adjusted EBITDA may not be consistent with that of other companies, and EBITDA and Adjusted EBITDA both have limitations as analytical tools and so should not be viewed in isolation but in conjunction with measurements that are computed in accordance with GAAP. Some of the limitations of EBITDA and Adjusted EBITDA are as follows:

  • EBITDA and Adjusted EBITDA do not reflect cash used for capital expenditures;
  • although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced and EBITDA and Adjusted EBITDA do not reflect the cash requirements for such replacements;
  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, working capital;
  • EBITDA and Adjusted EBITDA do not reflect the cash necessary to make payments of interest or principal on indebtedness; and
  • EBITDA and Adjusted EBITDA do not reflect the cash required to pay taxes.

REMINDER:

Members of Star’s management team will host a webcast and conference call at 11:00 a.m. Eastern Time tomorrow, August 3, 2023. The webcast will be accessible on the company’s website, at www.stargrouplp.com, and the telephone number for the conference call is 888-346-3470 (or 412-317-5169 for international callers).

About Star Group, L.P.

Star Group, L.P. is a full service provider specializing in the sale of home heating products and services to residential and commercial customers to heat their homes and buildings. The Company also sells and services heating and air conditioning equipment to its home heating oil and propane customers and, to a lesser extent, provides these offerings to customers outside of its home heating oil and propane customer base. Star also sells diesel, gasoline, and home heating oil on a delivery only basis. We believe Star is the nation’s largest retail distributor of home heating oil based upon sales volume. Including its propane locations, Star serves customers in the more northern and eastern states within the Northeast and Mid-Atlantic U.S. regions. Additional information is available by obtaining the Company’s SEC filings at www.sec.gov and by visiting Star’s website at www.stargrouplp.com, where unit holders may request a hard copy of Star’s complete audited financial statements free of charge.

Forward Looking Information

This news release includes “forward-looking statements” which represent the Company’s expectations or beliefs concerning future events that involve risks and uncertainties, including the impact of geopolitical events, such as the war in the Ukraine, and its impact on wholesale product cost volatility, the price and supply of the products that we sell, our ability to purchase sufficient quantities of product to meet our customer’s needs, rapid increases in levels of inflation approaching 40-year highs, uncertain economic conditions, the consumption patterns of our customers, our ability to obtain satisfactory gross profit margins, the effect of weather conditions on our financial performance, our ability to obtain new customers and retain existing customers, our ability to make strategic acquisitions, the impact of litigation, natural gas conversions, the impact of the novel coronavirus, or COVID-19, pandemic and future global health pandemics, on US and global economies, future union relations and the outcome of current and future union negotiations, the impact of current and future governmental regulations, including climate change, environmental, health, and safety regulations, the ability to attract and retain employees, customer credit worthiness, counterparty credit worthiness, marketing plans, cyber-attacks, increases in interest rates, global supply chain issues, labor shortages and new technology, including alternative methods for heating and cooling residences. All statements other than statements of historical facts included in this news release are forward-looking statements. Without limiting the foregoing, the words “believe,” “anticipate,” “plan,” “expect,” “seek,” “estimate” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct and actual results may differ materially from those projected as a result of certain risks and uncertainties. These risks and uncertainties include, but are not limited to, those set forth under the heading “Risk Factors” and “Business Strategy” in our Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended September 30, 2022. Important factors that could cause actual results to differ materially from the Company’s expectations (“Cautionary Statements”) are disclosed in this news release and in the Company’s Form 10-K and our Quarterly Reports on Form 10-Q. All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the Cautionary Statements. Unless otherwise required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this news release.

(financials follow)

 
STAR GROUP, L.P. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
 
    June 30,   September 30,

(in thousands)
  2023   2022
ASSETS   (unaudited)    
Current assets        
Cash and cash equivalents   $ 57,146     $ 14,620  
Receivables, net of allowance of $12,551 and $7,755, respectively     139,301       138,252  
Inventories     53,590       83,557  
Fair asset value of derivative instruments           16,823  
Prepaid expenses and other current assets     28,680       32,016  
Assets held for sale           2,995  
Total current assets     278,717       288,263  
Property and equipment, net     103,498       107,744  
Operating lease right-of-use assets     89,840       93,435  
Goodwill     254,354       254,110  
Intangibles, net     73,272       84,510  
Restricted cash     250       250  
Captive insurance collateral     68,351       66,662  
Deferred charges and other assets, net     16,068       17,501  
Total assets   $ 884,350     $ 912,475  
LIABILITIES AND PARTNERS’ CAPITAL        
Current liabilities        
Accounts payable   $ 29,010     $ 49,061  
Revolving credit facility borrowings     198       20,276  
Fair liability value of derivative instruments     10,398       183  
Current maturities of long-term debt     16,500       12,375  
Current portion of operating lease liabilities     17,617       17,211  
Accrued expenses and other current liabilities     135,267       125,561  
Unearned service contract revenue     63,446       62,858  
Customer credit balances     78,315       93,555  
Total current liabilities     350,751       381,080  
Long-term debt     135,394       151,709  
Long-term operating lease liabilities     77,323       81,385  
Deferred tax liabilities, net     15,731       25,620  
Other long-term liabilities     16,342       14,766  
Partners’ capital        
Common unitholders     307,199       277,177  
General partner     (4,103 )     (3,656 )
Accumulated other comprehensive loss, net of taxes     (14,287 )     (15,606 )
Total partners’ capital     288,809       257,915  
Total liabilities and partners’ capital   $ 884,350     $ 912,475  
         

 
STAR GROUP, L.P. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
    Three Months
Ended June 30,
  Nine Months
Ended June 30,

(in thousands, except per unit data – unaudited)
  2023   2022   2023   2022
                 
Sales:                
Product   $ 223,565     $ 358,236     $ 1,462,706     $ 1,481,963  
Installations and services     76,556       80,865       223,219       227,951  
Total sales     300,121       439,101       1,685,925       1,709,914  
Cost and expenses:                
Cost of product     169,097       291,236       1,054,457       1,058,164  
Cost of installations and services     66,596       70,560       211,450       214,744  
(Increase) decrease in the fair value of derivative instruments     (1,036 )     (7,669 )     19,622       (11,881 )
Delivery and branch expenses     83,075       83,914       276,953       280,389  
Depreciation and amortization expenses     7,684       8,067       23,147       24,596  
General and administrative expenses     6,065       6,251       19,619       18,829  
Finance charge income     (1,774 )     (1,762 )     (4,857 )     (3,300 )
Operating income (loss)     (29,586 )     (11,496 )     85,534       128,373  
Interest expense, net     (3,365 )     (2,635 )     (12,602 )     (7,422 )
Amortization of debt issuance costs     (245 )     (222 )     (832 )     (698 )
Income (loss) before income taxes   $ (33,196 )   $ (14,353 )   $ 72,100     $ 120,253  
Income tax expense (benefit)     (9,290 )     (3,766 )     20,426       34,972  
Net income (loss)   $ (23,906 )   $ (10,587 )   $ 51,674     $ 85,281  
General Partner’s interest in net income (loss)     (216 )     (93 )     468       726  
Limited Partners’ interest in net income (loss)   $ (23,690 )   $ (10,494 )   $ 51,206     $ 84,555  
                 
                 
Per unit data (Basic and Diluted):                
Net income (loss) available to limited partners   $ (0.67 )   $ (0.29 )   $ 1.43     $ 2.24  
Dilutive impact of theoretical distribution of earnings                 0.20       0.36  
Basic and diluted income (loss) per Limited Partner Unit:   $ (0.67 )   $ (0.29 )   $ 1.23     $ 1.88  
                 
Weighted average number of Limited Partner units outstanding (Basic and Diluted)     35,603       36,781       35,725       37,739  
                 

 
SUPPLEMENTAL INFORMATION

STAR GROUP, L.P. AND SUBSIDIARIES

RECONCILIATION OF EBITDA AND ADJUSTED EBITDA

(Unaudited)

 
    Three Months
Ended June 30,

(in thousands)
  2023   2022
Net loss   $ (23,906 )   $ (10,587 )
Plus:        
Income tax benefit     (9,290 )     (3,766 )
Amortization of debt issuance costs     245       222  
Interest expense, net     3,365       2,635  
Depreciation and amortization     7,684       8,067  
EBITDA     (21,902 )     (3,429 )
(Increase) / decrease in the fair value of derivative instruments     (1,036 )     (7,669 )
Adjusted EBITDA     (22,938 )     (11,098 )

Add / (subtract)
       
Income tax benefit     9,290       3,766  
Interest expense, net     (3,365 )     (2,635 )
Provision for losses on accounts receivable     3,742       3,097  
Decrease in accounts receivables     116,224       72,459  
Decrease (increase) in inventories     18,142       (1,924 )
Increase in customer credit balances     26,283       12,416  
Change in deferred taxes     2,095       3,292  
Change in other operating assets and liabilities     (32,925 )     (5,365 )
Net cash provided by operating activities   $ 116,548     $ 74,008  
Net cash used in investing activities   $ (1,481 )   $ (11,267 )
Net cash used in financing activities   $ (80,006 )   $ (71,459 )
         
         
Home heating oil and propane gallons sold     30,100       40,700  
Other petroleum products     35,900       38,100  
Total all products     66,000       78,800  
         

 

 
SUPPLEMENTAL INFORMATION

STAR GROUP, L.P. AND SUBSIDIARIES

RECONCILIATION OF EBITDA AND ADJUSTED EBITDA

(Unaudited)

 
    Nine Months
Ended June 30,

(in thousands)
  2023   2022
Net income   $ 51,674     $ 85,281  
Plus:        
Income tax expense     20,426       34,972  
Amortization of debt issuance costs     832       698  
Interest expense, net     12,602       7,422  
Depreciation and amortization     23,147       24,596  
EBITDA     108,681       152,969  
(Increase) / decrease in the fair value of derivative instruments     19,622       (11,881 )
Adjusted EBITDA     128,303       141,088  

Add / (subtract)
       
Income tax expense     (20,426 )     (34,972 )
Interest expense, net     (12,602 )     (7,422 )
Provision for losses on accounts receivable     8,510       5,264  
Increase in accounts receivables     (8,540 )     (92,604 )
Decrease (increase) in inventories     29,751       (19,972 )
Decrease in customer credit balances     (15,485 )     (38,497 )
Change in deferred taxes     (10,284 )     7,837  
Change in other operating assets and liabilities     3,488       7,845  
Net cash provided by (used in) operating activities   $ 102,715     $ (31,433 )
Net cash used in investing activities   $ (5,580 )   $ (24,770 )
Net cash (used in) provided by financing activities   $ (54,609 )   $ 60,400  
         
         
Home heating oil and propane gallons sold     240,400       276,700  
Other petroleum products     104,700       113,700  
Total all products     345,100       390,400  
         

Source: Star Group, L.P.

CONTACT:    
Star Group, L.P.   Chris Witty 
Investor Relations   Darrow Associates
203/328-7310   646/438-9385 or [email protected]



BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 9th, 2023, at 8:00 a.m. ET, to report second quarter 2023 financial results and provide business updates.

To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.

About BiomX

BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com.

BiomX, Inc.
Anat Primovich
Corporate Project Manager
+97250-6977228
[email protected]

Investor Relations:
LifeSci Advisors, LLC
John Mullaly
[email protected]

Source: BiomX Inc